// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Mediation analysis of CRP on the association of physical activity with FEV1 and FVC: the ECRHS study.

Elaine Fuertes - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

How does a physiotherapy-led remote monitoring service for home mechanical ventilation impact upon patient experience?

Denise Gibson - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Differential effect of ARDS on alveolar macrophage efferocytosis compared to bacterial phagocytosis

R Mahida - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Sepsis

N/A

Effects of maximal volitional hyperpnoea on exercise tolerance and locomotor muscle fatigue

Michael Johnson - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Investigating the safety of capsaicin cough challenge in severe asthma

Ran Wang - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Capsaicin

Do changes in spirometric indices and FeNO predict asthma outcomes in children? An individual patient data analysis using results from seven FeNO trials

Stephen Turner - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Type-2 CD8+ T lymphocytes responsive to PGD2/LTE4 in severe eosinophilic asthma

Timothy Hinks - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Prostaglandin

Interprofessional education (IPE) for respiratory care in neuromuscular disease (NMD) is feasible, and improves confidence in clinical practice

Alanna Hare - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Gastric antral vascular ectasia

N/A

Is there any added value of EBUS-TBNA to the identification of non-avid PET-CT lymph nodes?

Upul Pathirana - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Impact of once-daily single inhaler triple therapy on healthcare resource utilization and associated costs in COPD patients in Spain

Laura Atienza - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Measures of adherence in patients with severe asthma prescribed systemic steroids in the U-BIOPRED cohort

Fahad Alahmadi - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Prednisolone

Is integrated pulmonary and heart failure rehabilitation effective and safe in primary care?

Sudip Ghosh - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Congestive heart failure

N/A

Identification of significant late reactions from smaller exposures in specific inhalation challenge testing

Vicky Moore - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Oxygen alert cards versus Oxygen Alert Wrist Bands (OxyBand) in COPD

Emma Rickards - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Effects of double dose alpha 1 antitrypsin (AAT) therapy on cytokine pathways in AAT Deficiency (AATD)

Michael Campos - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Alpha-1 antitrypsin (A1AT) deficiency

Alpha 1-Antitrypsin

More household air pollution and COPD at higher altitude - a population-based, observational FRESH AIR study in rural Kyrgyzstan

Evelyn Brakema - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Alteration patterns of tobacco carcinogens in lung adenocarcinoma reveal novel KRAS-addicted candidate oncogenes

Mario Pepe - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Lung deposition of extrafine inhaled corticosteroid (ICS)-containing fixed combinations drug in COPD patients using Functional Respiratory Imaging (FRI).

Omar Usmani - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Defining the core components of a clinical review of people using continuous positive airway pressure (CPAP) therapy - an international e-Delphi study

Phyllis Murphie - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

What is a NICE definition of lung disease in patients with Cystic Fibrosis and its impact on treatment?

Georgina Dick - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

Copyright © 2026. QuantiNova All rights reserved